Summit Therapeutics Inc. Quarterly Return On Assets in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Summit Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q3 2024.
  • Summit Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -64.3 %, a 63% increase year-over-year.
  • Summit Therapeutics Inc. annual Return On Assets for 2023 was -269 %, a 781% decline from 2022.
  • Summit Therapeutics Inc. annual Return On Assets for 2022 was -30.5 %, a 54.5% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -64.3 +110 +63% Jul 1, 2024 Sep 30, 2024
Q2 2024 -68.8 +113 +62.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -55.5 +149 +72.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -269 -239 -781% Oct 1, 2023 Dec 31, 2023
Q3 2023 -174 -102 -141% Jul 1, 2023 Sep 30, 2023
Q2 2023 -182 -108 -144% Apr 1, 2023 Jun 30, 2023
Q1 2023 -205 -132 -179% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.5 +36.5 +54.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -72.1 -14.1 -24.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -74.7 -9.05 -13.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -73.4 -4.38 -6.34% Jan 1, 2022 Mar 31, 2022
Q4 2021 -67.1 Oct 1, 2021 Dec 31, 2021
Q3 2021 -58 Jul 1, 2021 Sep 30, 2021
Q2 2021 -65.7 Apr 1, 2021 Jun 30, 2021
Q1 2021 -69 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.